Mr Mrs Miss Ms Dr Other

Mr
Harry
Gregson

Senior Patent Attorney

London Office

Chemistry

Telephone. +44(0) 113 233 0100
Email. hgregson@hgf.com
Vcard
Linkedin

Experience

Harry is a Chartered UK and European Patent Attorney with extensive experience in drafting and prosecuting patent applications across a range of chemical fields, including pharmaceuticals, agrochemicals, organic synthesis, polymers, and medical devices.

Harry has worked closely with numerous start-ups and SMEs to develop tailored patent strategies aimed at securing robust protection aligned with their commercial objectives. He also regularly handles patent prosecution in jurisdictions outside Europe, including the USA, Japan, Australia, and India, and is therefore well-acquainted with the specific requirements and nuances of their patent systems.

Harry graduated with an MChem in Chemistry with Medicinal Chemistry from Newcastle University in 2018. During his degree, Harry spent a year in industry at a pharmaceutical manufacturing plant, where his work focused primarily on process development.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MCHEM

Chemistry with Medicinal Chemistry (with Industrial Training Year)

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate Intellectual Property

Publications

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

View publication online

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

View publication online

Exam Success!

View publication online

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us